Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Good Choice: Premier Patient Health Care Selects Choice Cancer Care as Oncology Provider

Business Wire December 22, 2014

EpiVax, Inc. enters license agreement with Novozymes Biopharma to advance pioneering treatment of autoimmune diseases

PR Newswire December 22, 2014

South Carolina teen chosen to promote tissue donation at Rose Parade

PR Newswire December 22, 2014

N30 Pharmaceuticals Appoints Jon Congleton as President and CEO

PR Newswire December 22, 2014

Welcome to an Elekta R&D update at University Medical Center Utrecht

Business Wire December 22, 2014

Research and Markets: The World Market for Tissue Diagnostics and Cell-Based Diagnostics (HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other Tests)

Business Wire December 22, 2014

Missed the Juno IPO? Take a Look at MabVax

Accesswire December 22, 2014

Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts

PR Newswire December 22, 2014

Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa

GlobeNewswire December 22, 2014

Genomind White Paper Describing the Clinical Utility of Pharmacogenetic Testing in Psychiatry Published in Psychiatry Journal

Marketwired December 22, 2014

Plandai Biotechnology, Inc. Announces Completion of $13 Million Production Facility

Marketwired December 22, 2014

Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease

Business Wire December 22, 2014

2014 Proves a Successful Year for Major Bioscience Fundings, Including Key Merger and Acquisition Activity in Colorado

Business Wire December 22, 2014

MEI Pharma Reaches Response Milestone in Phase II Clinical Trial of Pracinostat in Refractory Myelodysplastic Syndrome

PR Newswire December 22, 2014

Taiho Oncology Completes Submission of TAS-102 New Drug Application to the US Food and Drug Administration for the Treatment of Refractory Metastatic Colorectal Cancer

PR Newswire December 22, 2014

Pharmacyclics Announces Update on IMBRUVICA® (ibrutinib) Waldenstrom's macroglobulinemia (WM) Submission

PR Newswire December 22, 2014

Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV

GlobeNewswire December 22, 2014

FDA Grants Orphan Drug Designation to Nuvilex for Pancreatic Cancer Treatment

GlobeNewswire December 22, 2014

VBL Therapeutics Announces Positive Phase 2a Data for VB-111 in Recurrent Thyroid Cancer

GlobeNewswire December 22, 2014

Bio-Path Holdings to Initiate Development of Liposomal Bcl-2 in Follicular Lymphoma

Business Wire December 22, 2014